Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Xi'an Xintong Pharmaceutical Research Co.,Ltd.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects. | Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease | Not yet recruiting | Early phase 1 | 2026-02-12 | NCT07407634 | |
| Efficacy and Safety of Pracytarabine Versus Regorafenib in the Treatment of Patients With Hepatocellular Carcinoma | hepatocellular carcinoma | Active, not recruiting | Phase 2 / Phase 3 | 2025-12-31 | NCT07300488 | |
| A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 / Phase 3 | 2025-10-02 | NCT07203118 |